NEWS & EVENTS
RESOURCES
CONTACT
News and Events
April 21, 2010
BIOMEDevice Forum
Join us for the third annual BIOMEDevice Executive Forum as we focus
on convergence and cross-sector collaborations among biotechnology,
medical device, IVD, and pharmaceutical companies. This two-day conference
will provide you with the resources you need to strengthen connections
between key stakeholders involved in investing, partnering, licensing,
and developing business opportunities in the rapidly growing market
for innovative healthcare products. Topics addressed at this year's Forum will include:
- Regulatory & Reimbursement Issues
- Partnering & Collaborations
- Intellectual Property & Finance
- Technology & Innovation
News Stories from MassDevice.com:
July 30, 2010
Insurers who thought the public plan was a threat have another thing coming
Employers who promote individual health will have the greatest success at lowering employees' health care expenditures.
Read this story on MassDevice.com
Read this story on MassDevice.com
July 30, 2010
Cardiac Science Q2 losses soar on recall costs
Cardiac Science Corp. earnings take big dip due to an $11 million recall charge
Read this story on MassDevice.com
Read this story on MassDevice.com
July 30, 2010
Wall Street punishes Thoratec for lofty aspirations
Shares plunge by double digit percentages despite solid quarter where the Pleasenton, Calif. heart pump maker boosts bottom line 765 percent.
Read this story on MassDevice.com
Read this story on MassDevice.com
July 30, 2010
Plunging Taxus sales continue to put the hurt on Angiotech
Earnings at Angiotech Pharmaceuticals Inc. show that royalty revenues derived from sales of Boston Scientific Corp.'s Taxus drug-eluting stent continue dropped by 50 percent during Q2.
Read this story on MassDevice.com
Read this story on MassDevice.com
July 30, 2010
Covidien wins reversal of Becton Dickinson needle patents suit
A federal appeals court tosses a trial judge's $58 million damage award for Becton, Dickinson & Co. in the lastest round of a patent battle with Covidien Plc. over safety syringes.
Read this story on MassDevice.com
Read this story on MassDevice.com
July 30, 2010
Mass. Life Sciences Center adds Taligen Therapeutics CEO to board
Massachusetts Governor Deval Patrick appoints Taligen Therapeutics CEO Abbie Celniker to the Mass. Life Sciences Center board of directors.
Read this story on MassDevice.com
Read this story on MassDevice.com
July 30, 2010
CRL spikes $1.6 billion WuXi merger over shareholder concerns
Charles River Laboratories Inc. says it has terminated the merger agreement with WuXi PharmaTech (Cayman) Inc. over shareholder objections; Will pay $30 million break up fee.
Read this story on MassDevice.com
Read this story on MassDevice.com
July 30, 2010
Now Back to Sales
To know him is to love him. But would you take him home?
Read this story on MassDevice.com
Read this story on MassDevice.com
July 30, 2010
Insulet Corp. records 57% jump in 2Q revenues
Tubeless insulin-infusion device manufacturer Insulet Corp. racks up $22.9 million in second-quarter revenues, $8.2 million higher than year-ago sales, but profits remain a distant goal
Read this story on MassDevice.com
Read this story on MassDevice.com
July 29, 2010
BD's profits shrink 10 percent on tax provision
Becton, Dickinson and Company's profits drop 10 percent during the third quarter on a $34 million income tax provision; firm expands share repurchase program to $700 million.
Read this story on MassDevice.com
Read this story on MassDevice.com
July 29, 2010
FDA requires nine makers of needleless connectors to conduct post-market surveillance
Baxter, Carefusion and Becton Dickinson among nine companies told by federal regulators to study connections between displaced needleless connectors and higher rates of blood stream infections.
Read this story on MassDevice.com
Read this story on MassDevice.com
July 29, 2010
Medtronic aims to mitigate heart failure woes through the spine
Medtronic Inc. launches a global, randomized clinical trial of spinal cord stimulation as a treatment for slowing the progression of heart failure.
Read this story on MassDevice.com
Read this story on MassDevice.com
July 29, 2010
Zoll posts 285 percent increase in profits during Q3
Chelmsford, Mass-based Zoll Medical Corp. records another strong quarter based on increased sales in it's emergency medical services market.
Read this story on MassDevice.com
Read this story on MassDevice.com
July 29, 2010
Palomar's losses surge 600 percent
Palomar Medical Technologies Inc. second quarter losses increases 600 percent due to heavy spending in G&A and R&D expenditures; company says revenue growth was "steady."
Read this story on MassDevice.com
Read this story on MassDevice.com
July 29, 2010
Acquisitions pay off for Covidien in Q3, despite flat sales.
VNUS and Aspect Medical Systems buyouts boost the company's medical device business as Covidien Plc. posts $364 million profit on 2.6 billion in sales.
Read this story on MassDevice.com
Read this story on MassDevice.com
July 29, 2010
Tailoring the message to reach the accountable care organization mandate
In the new healthcare environment, it will also be necessary for medical device companies to communicate to its customers that they can help them achieve the broader goals associated with Accountable Care Organizations.
Read this story on MassDevice.com
Read this story on MassDevice.com
July 29, 2010
Orthopedics, stimulation carry the day for Orthofix
Orthofix International says earnings in June quarter were $10.2 million on $137.5 million in revenues; Raises 2010 guidance by 10 cents
Read this story on MassDevice.com
Read this story on MassDevice.com
July 29, 2010
Strong Q2 Prompts LeMaitre Vascular to Boost 2010 Guidance
LeMaitre Vascular turns in $1.5 million, second-quarter profit as sales climb 12% from year-ago levels; Firm says 2010 revenues should hit $55.8 million, up nearly $5 million from 2009
Read this story on MassDevice.com
Read this story on MassDevice.com
July 28, 2010
iCad's Q2 revenues rise, losses narrow
Second-quarter sales rose 6.4 percent for iCad Inc. as net losses narrow nearly 50 percent.
Read this story on MassDevice.com
Read this story on MassDevice.com
July 28, 2010
Varian Medical's Q3 sales rise, earnings stay flat
Varian Medical Systems posts a 13.4 percent revenue increase, but the bottom line ticks up a mere 0.1 percent on losses from the sale of its Accel lab instruments unit to Bruker Corp.
Read this story on MassDevice.com
Read this story on MassDevice.com